Lupin Q2 Results: Net profit soars 74% YoY to Rs 853 crore on strong demand for generic drugs

November 7, 2024

Lupin exceeded profit expectations in the second quarter, reporting a 74% surge in profits, reaching ₹8.53 billion. This growth was fueled by robust demand for their respiratory and diabetes medications. Overall revenue also saw an 11.3% increase, reaching ₹54.97 billion.

More To Explore

Stocks to buy: BPCL, Raymond Lifestyles and Ola Electric on investors’ radar

Benchmark indices ended flat amid a lack of near-term triggers. BPCL is advised to be avoided due to a lack of recovery signs. Raymond remains

December 27, 2024

Sanathan Textiles shares to list today. Here’s what GMP indicates

Sanathan Textiles shares are set to debut on the exchanges with an expected 27% premium over the issue price, driven by high investor demand. The

December 27, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003